VREO Stock Chart & Stats
C$14.68
-C$0.02(-0.15%)
At close: 4:00 PM EDT
C$14.68
-C$0.02(-0.15%)
Day’s Range― - ―
52-Week RangeC$12.57 - C$31.50
Previous CloseN/A
Volume1.77K
Average Volume (3M)16.53K
Market Cap
C$902.79M
Enterprise ValueC$1.14K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.31
Next Earnings
Nov 18, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.32
Shares Outstanding50,815,987
10 Day Avg. Volume25,175
30 Day Avg. Volume16,532
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.04
Revenue Forecast (FY)C$777.52M
Vireo Growth News
VREO FAQ
What was Vireo Growth’s price range in the past 12 months?
Vireo Growth lowest stock price was C$12.57 and its highest was C$31.50 in the past 12 months.
What is Vireo Growth’s market cap?
Vireo Growth’s market cap is C$902.79M.
When is Vireo Growth’s upcoming earnings report date?
Vireo Growth’s upcoming earnings report date is Nov 18, 2026 which is in 71 days.
How were Vireo Growth’s earnings last quarter?
Vireo Growth released its earnings results on Aug 11, 2026. The company reported C$0.324 earnings per share for the quarter, beating the consensus estimate of C$0.234 by C$0.09.
Is Vireo Growth overvalued?
According to Wall Street analysts Vireo Growth’s price is currently Overvalued.
Does Vireo Growth pay dividends?
Vireo Growth does not currently pay dividends.
What is Vireo Growth’s EPS estimate?
Vireo Growth’s EPS estimate is 0.32.
How many shares outstanding does Vireo Growth have?
Vireo Growth has 50,815,987 shares outstanding.
What happened to Vireo Growth’s price movement after its last earnings report?
Vireo Growth reported an EPS of C$0.324 in its last earnings report, beating expectations of C$0.234. Following the earnings report the stock price went up 3.01%.
Which hedge fund is a major shareholder of Vireo Growth?
Currently, no hedge funds are holding shares in TSE:VREO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vireo Growth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
93.18%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vireo Growth
Vireo Health International, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. Its products include medical marijuana extracts in the form of oils, vaporizers, and capsules. The company was founded on November 23, 2004 and is headquartered in Minneapolis, MN.
VREO Company Deck
VREO Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial trajectory: exceptionally large reported and pro forma revenue growth, a >$1B annualized run rate, improved adjusted EBITDA and near break‑even net loss, meaningful liquidity, and ambitious footprint expansion. Offsetting these positives are margin compression at the consolidated level driven by lower‑margin non‑cannabis additions and recently acquired businesses, plus execution and regulatory risk as multiple announced transactions await closing and integration.View all TSE:VREO earnings summariesTechnical Analysis
NeutriSci International
―
ZYUS Life Sciences
―
Luff Enterprises
―
―
Hash Corporation
―